SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Sum of short-term and long-term debt obligations
3Y CAGR
+0.1%/yr
Annual compound
5Y CAGR
-6.0%/yr
Recent acceleration
Percentile
P50
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $5.95M | +27.5% |
| 2024 | $4.67M | -21.0% |
| 2023 | $5.91M | -0.4% |
| 2022 | $5.93M | -30.4% |
| 2021 | $8.52M | +4.8% |
| 2020 | $8.13M | +6.4% |
| 2019 | $7.64M | - |